World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   4409 records for 1130 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
Not recruitingNCT02535026
An Observational Study on HER2 Status of Breast Invasive Carcinoma in Latin American Participants
26/08/2015
AuthorisedEUCTR2014-003863-40-ES
Study of MEDI4736 monotherapy and MEDI4736 in combination with Tremelimumab versus Standard of Care Therapy in patients with SCCHN
31/07/2015
AuthorisedEUCTR2013-002549-12-ES
PHASE 3, MULTICENTER, LONG-TERM OBSERVATIONAL STUDY OF SUBJECTS FROM TANEZUMAB STUDIES WHO UNDERGO A TOTAL KNEE, HIP OR SHOULDER REPLACEMENT
31/07/2015
Not recruitingNCT02504268
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
20/07/2015
Not RecruitingCTRI/2015/07/005984
Management of heart muscle injury following a non cardiac surgery to prevent death, heart attack and stroke.
08-07-2015
RecruitingNCT02477826
An Open-Label, Trial of Nivolumab and Nivolumab Plus Ipilimumab Versus Platinum Doublet Chemotherapy in Subjects With Stage IV Non-Small Cell Lung Cancer (NSCLC)
18/06/2015
AuthorisedEUCTR2014-004580-20-HU
Study to determine (find out) the Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients with Neovascular Age-related Macular Degeneration
Recruitment statusMain IDPublic titleDate of registration
RecruitingNCT02462486Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration02/06/2015
01/06/2015
RecruitingNCT02446912
Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
14/05/2015
AuthorisedEUCTR2014-004633-96-GB
A study to evaluate the efficacy and safety of two doses of Anifrolumab compared to placebo in adult patients with Active Systemic Lupus Erythematosus
08/05/2015
Not recruitingNCT02441426
Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development
04/05/2015
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history